PAULINE PAGEL: Open Payments
NPI 1215074638 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,767 in 74 payments from 21 companies in 2025. Trend: 2023 $1,439 · 2024 $1,540 · 2025 $1,767
Food & beverage: $1,725Education: $43
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $219 |
| Novo Nordisk Inc | 11 | $216 |
| Insulet Corporation | 7 | $216 |
| Medtronic, Inc. | 2 | $191 |
| Abbott Laboratories | 8 | $147 |
| SANOFI-AVENTIS U.S. LLC | 6 | $146 |
| Antares Pharma, Inc. | 4 | $80 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| Corcept Therapeutics | 2 | $67 |
| Dexcom, Inc. | 3 | $66 |
Products named: JARDIANCE, OMNIPOD, MINIMED 780G, FREESTYLE LIBRE 3, TZIELD, Ozempic, XYOSTED, GVOKE HYPOPEN.
Industry payments across TX — which companies pay providers there.
